Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology
Year: 2019
Type: review
Source: Toxicologic Pathology
Authors: Oliver C. Turner, Famke Aeffner, Dinesh S. Bangari, Wanda High, Brian Knight, Tom Forest, Brieuc Cossic, Lauren E. Himmel, Daniel G. Rudmann, Bhupinder Bawa, Anantharaman Muthuswamy, Olulanu H. Aina, Elijah F. Edmondson, Chandrassegar Saravanan, Danielle L. Brown, Tobias Sing, Manu M. Sebastian
Institutions: Amgen (United States), Boehringer Ingelheim (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), F. Hoffmann-La Roche AG, Vanderbilt University Medical Center, Charles River Laboratories (United States), AbbVie (United States), Regeneron (United States), National Institutes of Health, Frederick National Laboratory for Cancer Research, Novartis (Switzerland), Novartis Institutes for BioMedical Research, The University of Texas MD Anderson Cancer Center
Language: English
Topic: AI in cancer detection
Subfield: Artificial Intelligence
Field: Computer Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2981553472
